Squarepoint
NURO

Squarepoint’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Squarepoint’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,708
Closed -$220K – 3619
2021
Q3 		$220K Buy
+2,708
New +$242K ﹤0.01% 2433
2021
Q2 		– Sell
-2,692
Closed -$73K – 3821
2021
Q1 		$73K Buy
+2,692
New +$81.6K ﹤0.01% 2957

Other funds holding NURO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SC
Stephens Consulting Flint, Michigan $309M AUM 14.46% 1-Year Est. Return

Squarepoint's NURO Position: Q4 2021 in Review

Squarepoint sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q4 2021, closing a stake of 2,708 shares — an estimated $220K sold.

Squarepoint first reported a position in NURO in Q1 2021 and held it in 2 quarters. The position peaked at $220K in Q3 2021. 17 funds tracked by Wall St. Rank hold NURO as of Q4 2021.

  • Squarepoint reported no remaining NeuroMetrix, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Squarepoint sold 2,708 NeuroMetrix, Inc. Common Stock shares in Q4 2021, an estimated $220K.
  • Squarepoint first reported a position in NeuroMetrix, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Squarepoint's NeuroMetrix, Inc. Common Stock position peaked at $220K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q4 2021.

Based on Squarepoint's 13F filing for Q4 2021, filed 14 Feb 2022.